Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.
about
Phage display-derived peptides for osteosarcoma imagingRho GTPase-activating protein 35 rs1052667 polymorphism and osteosarcoma risk and prognosis.Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcomaCyclin E1 is amplified and overexpressed in osteosarcoma.Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice.Genetically engineered mouse models and human osteosarcoma.Elevated ASCL2 expression is associated with metastasis of osteosarcoma and predicts poor prognosis of the patientsCurrent status and perspectives regarding the treatment of osteo-sarcoma: chemotherapyCelastrol negatively regulates cell invasion and migration ability of human osteosarcoma via downregulation of the PI3K/Akt/NF-κB signaling pathway in vitro.Resveratrol reverses P-glycoprotein-mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF-κB and p38 MAPK signaling pathways.50 years ago in CORR: the present trend in treatment of osteogenic sarcoma.Prognostic significance of HLA EMR8-5 immunohistochemically analyzed expression in osteosarcoma.Emerging drugs for high-grade osteosarcoma.Current therapeutic strategies and novel approaches in osteosarcoma.The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma.Hyperthermia effect and antibacterial efficacy of Fe(3+) /Co(2+) co-substitutions in β-Ca3 (PO4 )2 for bone cancer and defect therapy.Metastatic osteosarcoma: a challenging multidisciplinary treatment.Glucocorticoid receptor DNA binding factor 1 expression and osteosarcoma prognosis.In vitro evaluation of glass-glass ceramic thermoseed-induced hyperthermia on human osteosarcoma cell line.Corosolic acid triggers mitochondria and caspase-dependent apoptotic cell death in osteosarcoma MG-63 cells.Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models.MiR-374a promotes the proliferation of human osteosarcoma by downregulating FOXO1 expression.Oxycodone Resistance Due to Rifampin Use in an Osteosarcoma Patient with Tuberculosis.Upregulation of long noncoding RNA Xist promotes proliferation of osteosarcoma by epigenetic silencing of P21.Antitumor activity of resveratrol against human osteosarcoma cells: a key role of Cx43 and Wnt/β-catenin signaling pathway.Mdm2 selectively suppresses DNA damage arising from inhibition of topoisomerase II independent of p53.Effects of SOST Gene Silencing on Proliferation, Apoptosis, Invasion, and Migration of Human Osteosarcoma Cells Through the Wnt/β-Catenin Signaling Pathway.MicroRNA-150 functions as a tumor suppressor in osteosarcoma by targeting IGF2BP1.The miR-17-92 cluster/QKI2/β-catenin axis promotes osteosarcoma progression.Mitoxantrone induces apoptosis in osteosarcoma cells through regulation of the Akt/FOXO3 pathway.Conjugation of amino-bioactive glasses with 5-aminofluorescein as probe molecule for the development of pH sensitive stimuli-responsive biomaterials
P2860
Q33613448-C7A9C11C-C594-4EC7-9A00-CA24BFF21858Q34014581-30009C3E-2B31-4993-9296-D44F4D58D756Q34365891-59AEFB7E-96EF-4B74-A2A3-36B8FB46B90BQ34801120-FF166D9A-146C-4503-9BA6-529391B9BD20Q34829069-FBC484FC-F13D-4F8A-A05F-D192EA36261BQ36468644-636F249D-5AFA-4212-8828-290F453BD56CQ37077429-D518A91E-16B6-42B2-A46D-CD1BC2CE94E8Q37265109-EB6B1E10-6FB3-46B5-9346-0EEE26431F39Q37406992-4875106C-F64D-447C-BD6B-01103F462684Q37407335-C928DCCB-D487-430F-9AA3-5B352813133FQ37585134-6AD68CB1-68DF-498C-BC01-9A9E97C7CD63Q37703330-EE335BCE-C2D0-4776-A6AC-C6F073058172Q37778400-30A04E7F-8183-475D-BE3B-C000FC1E5900Q38161735-23D57037-DEE3-40FD-98E5-EAF43EF46922Q38267782-795A9A05-C0FF-4267-BC3D-616BB3857515Q38698646-A914F356-0D9E-47E9-9D8F-A89C4965AD14Q38783252-460BD382-DF87-4EDB-9B5A-3372055FEB70Q38960156-CB7B4034-E780-4049-8C67-61125F17EEB2Q39463163-1B515FDD-3786-40F0-84D0-45994273B9D1Q39588134-09FD2BE7-4243-4914-A3DD-022EEF00E227Q39751683-F403CF76-34E2-433E-A97D-1FA6B7D8883DQ40846602-986B9C27-518A-47F5-9E41-E3D72A2CCA3AQ43237514-D421CF46-BCF3-4957-AD88-6106CB31A24AQ47116187-249B8101-A9AC-4C16-A520-379FEFCFB2A8Q49399012-1092A181-45C9-4E3F-8347-B8B45D308337Q50899909-0A7E5A08-C21B-4D79-A082-A293A8B4B1E9Q51117850-207ADB11-E178-46B2-90AE-4634C5F796D6Q53280332-E20DB008-1947-407A-AE2C-C236932E825EQ55078467-078759AD-CBB2-4418-992E-D3DD66332612Q55180297-82D4A06A-8C56-4BBF-894E-569BC48A9476Q57162669-45DEAC21-A0AD-49B9-8679-0C9BFB440A05
P2860
Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.
@ast
Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.
@en
type
label
Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.
@ast
Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.
@en
prefLabel
Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.
@ast
Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.
@en
P2093
P2860
P356
P1476
Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies
@en
P2093
Céline Chipoy
François Gouin
François Lamoureux
Françoise Redini
Valérie Trichet
P2860
P304
P356
10.1586/14737140.7.2.169
P577
2007-02-01T00:00:00Z